Aster Capital Management’s Zenas BioPharma ZBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBIO
Aster Capital Management's ZBIO Position: Q3 2026 in Review
Aster Capital Management opened a new position in Zenas BioPharma (ZBIO) in Q3 2026: 378 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in ZBIO as recently as Q4 2025.
Aster Capital Management first reported a position in ZBIO in Q3 2024 and has held it in 4 quarters since. The position peaked at $51.1K in Q3 2024. 153 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.
- Aster Capital Management held 378 shares of Zenas BioPharma worth $10.2K as of Q3 2026.
- Zenas BioPharma was a new Aster Capital Management position in Q3 2026.
- Zenas BioPharma made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #777 holding.
- Aster Capital Management first reported a position in Zenas BioPharma in Q3 2024 and has held it in 4 quarters since.
- Aster Capital Management's Zenas BioPharma position peaked at $51.1K in Q3 2024.
- 153 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.